Cargando…
Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619591/ https://www.ncbi.nlm.nih.gov/pubmed/34830176 http://dx.doi.org/10.3390/ijms222212295 |